Pacira BioSciences (PCRX) Non-Current Deffered Revenue (2010 - 2022)

Pacira BioSciences (PCRX) recorded quarterly Non-Current Deffered Revenue of $10.1 million in Q1 2022, little changed quarter-over-quarter from $10.1 million in Q4 2021.

Pacira BioSciences (PCRX) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends

Pacira BioSciences' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $10.1 million for Q1 2022.

  • In Q1 2022, Non-Current Deffered Revenue changed N/A year-over-year to $10.1 million; the TTM figure through Mar 2022 stood at $10.1 million (changed N/A YoY), while the FY2021 annual figure was $10.1 million, changed N/A from the prior year.
  • Non-Current Deffered Revenue was $10.1 million for Q1 2022 at Pacira BioSciences, roughly flat from $10.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $10.1 million in Q4 2021 to a low of $10.1 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Pacira BioSciences 935.46 Mn 733.28 Mn 140.96 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 10.13 Mn
Dec 31, 2021 10.13 Mn
Mar 31, 2017 7.36 Mn
Dec 31, 2016 7.49 Mn
Sep 30, 2016 7.62 Mn
Jun 30, 2016 7.75 Mn
Mar 31, 2016 7.88 Mn
Dec 31, 2015 8.08 Mn
Sep 30, 2015 8.44 Mn
Jun 30, 2015 8.80 Mn
Mar 31, 2015 9.15 Mn
Dec 31, 2014 9.51 Mn
Sep 30, 2014 9.86 Mn
Jun 30, 2014 10.22 Mn
Mar 31, 2014 2.96 Mn
Dec 31, 2013 3.21 Mn
Sep 30, 2013 2.99 Mn
Jun 30, 2013 3.23 Mn
Mar 31, 2013 3.48 Mn
Dec 31, 2012 3.72 Mn